AAAAAA

   
Results: 1-25 | 26-37
Results: 1-25/37
RESULTS OF ALLOGENEIC BONE-MARROW TRANSPLANTS FOR LEUKEMIA USING DONORS OTHER THAN HLA-IDENTICAL SIBLINGS
Authors: SZYDLO R GOLDMAN JM KLEIN JP GALE RP ASH RC BACH FH BRADLEY BA CASPER JT FLOMENBERG N GAJEWSKI JL GLUCKMAN E HENSLEEDOWNEY PJ HOWS JM JACOBSEN N KOLB HJ LOWENBERG B MASAOKA T ROWLINGS PA SONDEL PM VANBEKKUM DW VANROOD JJ VOWELS MR ZHANG MJ HOROWITZ MM
Citation: R. Szydlo et al., RESULTS OF ALLOGENEIC BONE-MARROW TRANSPLANTS FOR LEUKEMIA USING DONORS OTHER THAN HLA-IDENTICAL SIBLINGS, Journal of clinical oncology, 15(5), 1997, pp. 1767-1777
EFFECT OF T-CELL SUBSET DOSE ON OUTCOME OF T-CELL-DEPLETED BONE-MARROW TRANSPLANTATION
Authors: KAWANISHI Y PASSWEG J DROBYSKI WR ROWLINGS P COOKCRAIG A CASPER J PIETRYGA D GARBRECHT F CAMITTA B HOROWITZ M JUCKETT M MARGOLIS D FLOMENBERG N KEEVERTAYLOR CA
Citation: Y. Kawanishi et al., EFFECT OF T-CELL SUBSET DOSE ON OUTCOME OF T-CELL-DEPLETED BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 19(11), 1997, pp. 1069-1077
ASSOCIATION OF DONOR-DERIVED HOST-REACTIVE CYTOLYTIC AND HELPER T-CELLS WITH OUTCOME FOLLOWING ALTERNATIVE DONOR T-CELL-DEPLETED BONE-MARROW TRANSPLANTATION
Authors: KEEVERTAYLOR CA PASSWEG J KAWANISHI Y CASPER J FLOMENBERG N BAXTERLOWE LA
Citation: Ca. Keevertaylor et al., ASSOCIATION OF DONOR-DERIVED HOST-REACTIVE CYTOLYTIC AND HELPER T-CELLS WITH OUTCOME FOLLOWING ALTERNATIVE DONOR T-CELL-DEPLETED BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 19(10), 1997, pp. 1001-1009
HLA DISPARITY DETECTED BY AUTOMATED NUCLEOTIDE SEQUENCING MAY AID IN SELECTION OF ALTERNATIVE DONORS
Authors: BAXTERLOWE LA PARRISH R MARGOLIS D SZMANIA S SEURYNCK K WHITE J WANK T MOLTER M HAZLETT L DROBYSKI W GARBRECHT F PIETRYGA D HOROWITZ M CAMITTA B VESOLE D BURNS W FLOMENBERG N CASPER J KEEVERTAYLOR C
Citation: La. Baxterlowe et al., HLA DISPARITY DETECTED BY AUTOMATED NUCLEOTIDE SEQUENCING MAY AID IN SELECTION OF ALTERNATIVE DONORS, Blood, 90(10), 1997, pp. 478-478
EFFECTS OF PURINE ANALOGS ALONE OR IN COMBINATION WITH CD4 ANALOGS ONBONE-MARROW AND SKIN TRANSPLANTATION
Authors: FILICKO J KOCH U CHOKSI S FLOMENBERG N KORNGOLD R
Citation: J. Filicko et al., EFFECTS OF PURINE ANALOGS ALONE OR IN COMBINATION WITH CD4 ANALOGS ONBONE-MARROW AND SKIN TRANSPLANTATION, Blood, 90(10), 1997, pp. 1603-1603
USE OF MOLECULAR HLA ANALYSIS TO EXAMINE THE RELATIONSHIP BETWEEN CLASS-II HLA DISPARITY AND OUTCOME OF UNRELATED BONE-MARROW TRANSPLANTS
Authors: BAXTERLOWE LA KOLLMAN C AWDEH Z BEATTY P BEGOVICH A CONFER D FERNANDEZVINA M FLOMENBERG N KITAJIMA D NOREEN H SALAZAR M SCHMECKPEPER B WILLIAMS T YUNIS E HURLEY C
Citation: La. Baxterlowe et al., USE OF MOLECULAR HLA ANALYSIS TO EXAMINE THE RELATIONSHIP BETWEEN CLASS-II HLA DISPARITY AND OUTCOME OF UNRELATED BONE-MARROW TRANSPLANTS, Blood, 90(10), 1997, pp. 1764-1764
IDENTIFICATION OF A NEW DQB1-ASTERISK-0613 ALLELE IN A FAMILY
Authors: HSU SH ROBBINS FM MODELO RB BRUNNER J FLOMENBERG N
Citation: Sh. Hsu et al., IDENTIFICATION OF A NEW DQB1-ASTERISK-0613 ALLELE IN A FAMILY, Tissue antigens, 50(6), 1997, pp. 685-687
UNRELATED DONOR BONE-MARROW TRANSPLANTATION TO TREAT SEVERE APLASTIC-ANEMIA IN CHILDREN AND YOUNG-ADULTS
Authors: MARGOLIS D CAMITTA B PIETRYGA D KEEVERTAYLOR C BAXTERLOWE LA PIERCE K KUPST MJ FRENCH J TRUITT R LAWTON C MURRAY K GARBRECHT F FLOMENBERG N CASPER J
Citation: D. Margolis et al., UNRELATED DONOR BONE-MARROW TRANSPLANTATION TO TREAT SEVERE APLASTIC-ANEMIA IN CHILDREN AND YOUNG-ADULTS, British Journal of Haematology, 94(1), 1996, pp. 65-72
BONE-MARROW TRANSPLANTATION (BMT) USING GENOTYPICALLY HAPLOIDENTICAL DONORS
Authors: PIETRYGA D CASPER J MARGOLIS D CAMITTA B GARBRECHT F DROBYSKI W HOROWITZ M BURNS W JUCKETT M ROWLINGS P PASSWEG J LAWTON C TAYLOR C BAXTERLOWE L MURRAY K PIERCE K MCAULIFFE T FLOMENBERG N
Citation: D. Pietryga et al., BONE-MARROW TRANSPLANTATION (BMT) USING GENOTYPICALLY HAPLOIDENTICAL DONORS, Blood, 88(10), 1996, pp. 1044-1044
ASSOCIATION OF HOST-REACTIVE CYTOLYTIC AND HELPER T-CELLS WITH OUTCOME FOLLOWING ALTERNATIVE DONOR T-CELL DEPLETED BONE-MARROW TRANSPLANTATION
Authors: KEEVERTAYLOR CA PASSWEG J KAWANISHI Y CASPER J FLOMENBERG N BAXTERLOWE LA
Citation: Ca. Keevertaylor et al., ASSOCIATION OF HOST-REACTIVE CYTOLYTIC AND HELPER T-CELLS WITH OUTCOME FOLLOWING ALTERNATIVE DONOR T-CELL DEPLETED BONE-MARROW TRANSPLANTATION, Blood, 88(10), 1996, pp. 1827-1827
HLA-B14 SUBTYPES AND THEIR INFLUENCE ON ALLORECOGNITION
Authors: GILMAN AL AUGER JJ TERRY L FLOMENBERG N BAXTERLOWE LA
Citation: Al. Gilman et al., HLA-B14 SUBTYPES AND THEIR INFLUENCE ON ALLORECOGNITION, Tissue antigens, 47(3), 1996, pp. 253-256
THERAPEUTIC PLASMA-EXCHANGE DOES NOT APPEAR TO BE EFFECTIVE IN THE MANAGEMENT OF THROMBOTIC THROMBOCYTOPENIC PURPURA HEMOLYTIC-UREMIC SYNDROME FOLLOWING BONE-MARROW TRANSPLANTATION
Authors: SARODE R MCFARLAND JG FLOMENBERG N CASPER JT COHEN EP DROBYSKI WR ASH RC HOROWITZ MM CAMITTA B LAWTON C GARBRECHT F GOTTSCHALL JL
Citation: R. Sarode et al., THERAPEUTIC PLASMA-EXCHANGE DOES NOT APPEAR TO BE EFFECTIVE IN THE MANAGEMENT OF THROMBOTIC THROMBOCYTOPENIC PURPURA HEMOLYTIC-UREMIC SYNDROME FOLLOWING BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 16(2), 1995, pp. 271-275
PHASE-III RANDOMIZED, DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF RHGM-CSF FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION
Authors: NEMUNAITIS J ROSENFELD CS ASH R FREEDMAN MH DEEG HJ APPELBAUM F SINGER JW FLOMENBERG N DALTON W ELFENBEIN GJ RIFKIN R RUBIN A AGOSTI J HAYES FA HOLCENBERG J SHADDUCK RK
Citation: J. Nemunaitis et al., PHASE-III RANDOMIZED, DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF RHGM-CSF FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 15(6), 1995, pp. 949-954
CHARACTERIZATION OF THE ALLOREACTIVITY AND ANTILEUKEMIA REACTIVITY OFCORD-BLOOD MONONUCLEAR-CELLS
Authors: KEEVER CA ABUHAJIR M GRAF W MCFADDEN P PRICHARD P OBRIEN J FLOMENBERG N
Citation: Ca. Keever et al., CHARACTERIZATION OF THE ALLOREACTIVITY AND ANTILEUKEMIA REACTIVITY OFCORD-BLOOD MONONUCLEAR-CELLS, Bone marrow transplantation, 15(3), 1995, pp. 407-419
USE OF SOLID-PHASE AUTOMATED SEQUENCING TO DEFINE HLA DISPARITY BETWEEN BONE-MARROW DONORS AND RECIPIENTS
Authors: BAXTERLOWE LA KEEVER C DINAUER D DANIELS T JOHNSON K CAMITTA B DROBYSKI W GARBRECHT F HOROWITZ M PIETRYGA D CASPER J FLOMENBERG N
Citation: La. Baxterlowe et al., USE OF SOLID-PHASE AUTOMATED SEQUENCING TO DEFINE HLA DISPARITY BETWEEN BONE-MARROW DONORS AND RECIPIENTS, Transplantation proceedings, 27(1), 1995, pp. 1377-1378
CIRCULATING T-CELL REPERTOIRE COMPLEXITY IN NORMAL INDIVIDUALS AND BONE-MARROW RECIPIENTS ANALYZED BY CDR3 SIZE SPECTRATYPING - CORRELATIONWITH IMMUNE STATUS (VOL 152, PG 5109, 1994)
Authors: GORSKI J YASSAI M ZHU XL KISSELA B KEEVER C FLOMENBERG N
Citation: J. Gorski et al., CIRCULATING T-CELL REPERTOIRE COMPLEXITY IN NORMAL INDIVIDUALS AND BONE-MARROW RECIPIENTS ANALYZED BY CDR3 SIZE SPECTRATYPING - CORRELATIONWITH IMMUNE STATUS (VOL 152, PG 5109, 1994), The Journal of immunology, 154(3), 1995, pp. 1521-1521
HUMAN CD8 TRANSGENE REGULATION OF HLA RECOGNITION BY MURINE T-CELLS
Authors: LAFACE DM VESTBERG M YANG Y SRIVASTAVA R DISANTO J FLOMENBERG N BROWN S SHERMAN LA PETERSON PA
Citation: Dm. Laface et al., HUMAN CD8 TRANSGENE REGULATION OF HLA RECOGNITION BY MURINE T-CELLS, The Journal of experimental medicine, 182(5), 1995, pp. 1315-1325
USE OF UNRELATED MARROW GRAFTS COMPENSATES FOR REDUCED GRAFT-VERSUS-LEUKEMIA REACTIVITY AFTER T-CELL DEPLETED ALLOGENEIC BMT FOR CHRONIC MYELOGENOUS LEUKEMIA
Authors: HESSNER M ENDEAN D CASPER J HOROWITZ M TAYLOR C ROTH M FLOMENBERG N DROBYSKI W
Citation: M. Hessner et al., USE OF UNRELATED MARROW GRAFTS COMPENSATES FOR REDUCED GRAFT-VERSUS-LEUKEMIA REACTIVITY AFTER T-CELL DEPLETED ALLOGENEIC BMT FOR CHRONIC MYELOGENOUS LEUKEMIA, Blood, 86(10), 1995, pp. 1143-1143
USE OF UNRELATED MARROW GRAFTS COMPENSATES FOR REDUCED GRAFT-VERSUS-LEUKEMIA REACTIVITY AFTER T-CELL-DEPLETED ALLOGENEIC MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA
Authors: HESSNER MJ ENDEAN DJ CASPER JT HOROWITZ MM KEEVERTAYLOR CA ROTH M FLOMENBERG N DROBYSKI WR
Citation: Mj. Hessner et al., USE OF UNRELATED MARROW GRAFTS COMPENSATES FOR REDUCED GRAFT-VERSUS-LEUKEMIA REACTIVITY AFTER T-CELL-DEPLETED ALLOGENEIC MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA, Blood, 86(10), 1995, pp. 3987-3996
UNRELATED BONE-MARROW DONOR TRANSPLANTS FOR CHILDREN WITH LEUKEMIA ORMYELODYSPLASIA
Authors: CASPER J CAMITTA B TRUITT R BAXTERLOWE LA BUNIN N LAWTON C MURRAY K HUNTER J PIETRYGA D GARBRECHT F KEEVER C DROBYSKI W HOROWITZ M FLOMENBERG N ASH R
Citation: J. Casper et al., UNRELATED BONE-MARROW DONOR TRANSPLANTS FOR CHILDREN WITH LEUKEMIA ORMYELODYSPLASIA, Blood, 85(9), 1995, pp. 2354-2363
HYPERFRACTIONATED TOTAL LYMPHOID IRRADIATION AND CYCLOPHOSPHAMIDE FORPREPARATION OF PREVIOUSLY TRANSFUSED PATIENTS UNDERGOING HLA-IDENTICAL MARROW TRANSPLANTATION FOR SEVERE APLASTIC-ANEMIA
Authors: CASTROMALASPINA H CHILDS B LAVER J SHANK B BROCHSTEIN J GILLIO A FLOMENBERG N YOUNG J BOULAD F BLACK P KERNAN N FUKS Z OREILLY R
Citation: H. Castromalaspina et al., HYPERFRACTIONATED TOTAL LYMPHOID IRRADIATION AND CYCLOPHOSPHAMIDE FORPREPARATION OF PREVIOUSLY TRANSFUSED PATIENTS UNDERGOING HLA-IDENTICAL MARROW TRANSPLANTATION FOR SEVERE APLASTIC-ANEMIA, International journal of radiation oncology, biology, physics, 29(4), 1994, pp. 847-854
LISOFYLLINE, A PHOSPHOLIPID SIGNALING INHIBITOR APPEARS TO ACCELERATETRILINEAGE ENGRAFTMENT FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION
Authors: SCHUSTER M NEMUNAITIS J LIST A KURTZBERG J FLOMENBERG N SINGER JW BIANCO JA
Citation: M. Schuster et al., LISOFYLLINE, A PHOSPHOLIPID SIGNALING INHIBITOR APPEARS TO ACCELERATETRILINEAGE ENGRAFTMENT FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION, Experimental hematology, 22(8), 1994, pp. 697-697
CIRCULATING T-CELL REPERTOIRE COMPLEXITY IN NORMAL INDIVIDUALS AND BONE-MARROW RECIPIENTS ANALYZED BY CDR3 SIZE SPECTRATYPING - CORRELATIONWITH IMMUNE STATUS
Authors: GORSKI J YASSAI M ZHU XL KISSELLA B KEEVER C FLOMENBERG N
Citation: J. Gorski et al., CIRCULATING T-CELL REPERTOIRE COMPLEXITY IN NORMAL INDIVIDUALS AND BONE-MARROW RECIPIENTS ANALYZED BY CDR3 SIZE SPECTRATYPING - CORRELATIONWITH IMMUNE STATUS, The Journal of immunology, 152(10), 1994, pp. 5109-5119
PHASE-I CONCENTRATION-CONTROLLED, ESCALATION TRIAL OF LISOFYLLINE (LSF) IN PATIENTS (PTS) UNDERGOING ALLOGENEIC BONE-MARROW TRANSPLANTATION(BMT)
Authors: LIST A SHUSTER M BLAZAR B ELFENBEIN G NEMUNAITIS J FLOMENBERG N KURTZBERG J BAKKE L THOELKE K SINGER JW BIANCO JA
Citation: A. List et al., PHASE-I CONCENTRATION-CONTROLLED, ESCALATION TRIAL OF LISOFYLLINE (LSF) IN PATIENTS (PTS) UNDERGOING ALLOGENEIC BONE-MARROW TRANSPLANTATION(BMT), Blood, 84(10), 1994, pp. 10000089-10000089
CORRELATION OF T-CELL DOSE AND CTL PRECURSOR FREQUENCY WITH GRAFT-VERSUS-HOST DISEASE AND SURVIVAL AFTER UNRELATED OR PARTIALLY MATCHED RELATED BMT
Authors: KEEVER CA KAWANISHI Y WANK T CHALTRY M CRAIG A DROBYSKI W HOROWITZ M CASPER J CAMITTA B PIETRYGA D GARBRECHT F FLOMENBERG N BAXTERLOWE LA
Citation: Ca. Keever et al., CORRELATION OF T-CELL DOSE AND CTL PRECURSOR FREQUENCY WITH GRAFT-VERSUS-HOST DISEASE AND SURVIVAL AFTER UNRELATED OR PARTIALLY MATCHED RELATED BMT, Blood, 84(10), 1994, pp. 10000099-10000099
Risultati: 1-25 | 26-37